✂ Fed’s first rate cut since 2020: Use our free Stock Screener to find new opportunities fastExplore for FREE

China clears Johnson & Johnson baby products after probe

Published 03/21/2009, 01:58 AM
Updated 03/21/2009, 02:08 AM
CARR
-

BEIJING, March 21 (Reuters) - Chinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by U.S. company Johnson & Johnson.

The State Food and Drug Administration had investigated 33 products, including baby shampoo, made by Johnson & Johnson after a U.S. consumer group charged that they contained carcinogens.

The SFDA, in a statement on its website, said it would continue to monitor the situation and carry out timely tests.

Johnson & Johnson has disputed the allegations by the U.S.-based Campaign for Safe Cosmetics, saying that trace levels of the compounds in question result from processes that make the products gentle for babies and safe from bacteria growth.

The U.S. Food and Drug Administration and other government agencies consider these trace level safe, the company said in a statement this week.

According to media reports, a Shanghai-based regional supermarket chain, Nonggongshang Supermarket Group, ordered its 3,500 outlets to remove baby bath products made by Johnson & Johnson from their shelves.

Other big outlets in China, including the U.S. supermarket Wal-Mart Stores and its French rival Carrefour, still carry the products. (Reporting by Simon Rabinovitch; Editing by Jan Dahinten)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.